BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29495005)

  • 1. Elevated HPV16 E1 Expression Is Associated with Cervical Cancer Progression.
    Baedyananda F; Chaiwongkot A; Bhattarakosol P
    Intervirology; 2017; 60(5):171-180. PubMed ID: 29495005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation.
    Dutta S; Chakraborty C; Dutta AK; Mandal RK; Roychoudhury S; Basu P; Panda CK
    J Clin Pathol; 2015 Mar; 68(3):206-11. PubMed ID: 25563334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
    Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
    Mazumder Indra D; Singh RK; Mitra S; Dutta S; Chakraborty C; Basu PS; Mondal RK; Roychoudhury S; Panda CK
    Gynecol Oncol; 2011 Dec; 123(3):597-604. PubMed ID: 21911249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus Type 16
    Yao Y; Yan Z; Dai S; Li C; Yang L; Liu S; Zhang X; Shi L; Yao Y
    Int J Med Sci; 2019; 16(7):1042-1049. PubMed ID: 31341418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
    Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
    Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
    Hong D; Liu J; Hu Y; Lu X; Li B; Li Y; Hu D; Lu W; Xie X; Cheng X
    BMC Cancer; 2017 Feb; 17(1):136. PubMed ID: 28202002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
    Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
    Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of hnRNP E1 and both early genes E2 and E6 of HPV16 together with their interactions on cervical carcinogenesis].
    Lyu YJ; Ding L; Li QL; Li L; Wang M; Han Y; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Apr; 40(4):466-470. PubMed ID: 31006210
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization and whole genome analysis of human papillomavirus type 16 e1-1374^63nt variants.
    Sabol I; Matovina M; Si-Mohamed A; Grce M
    PLoS One; 2012; 7(7):e41045. PubMed ID: 22911739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions.
    Paolini F; Curzio G; Melucci E; Terrenato I; Antoniani B; Carosi M; Mottolese M; Vici P; Mariani L; Venuti A
    Eur J Cancer; 2016 May; 58():52-61. PubMed ID: 26963794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
    Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
    Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
    Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
    Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B; Xue M
    Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship among HPV16 infection and Expression of hTERT, p21waf1, Ki67 in cervical intraepithelial neoplasias and squamous cell carcinomas of cervix uteri].
    Zhao FX; Sun RF; Wang JF; Chen XW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):370-4. PubMed ID: 16415998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
    Sun C; Reimers LL; Burk RD
    Gynecol Oncol; 2011 Apr; 121(1):59-63. PubMed ID: 21306759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
    Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.